OpGen Goes Public at $6 Per Unit | GenomeWeb

NEW YORK (GenomeWeb) – OpGen today went public with an offering of 2.85 million units at $6 per unit for $17.1 million in gross proceeds. 

Each unit consists of one share of common stock and a warrant to purchase one share of common stock. The stocks and warrants have been approved to list on the Nasdaq Capital Market and will immediately and automatically separate upon issuance, OpGen said. Each of the common stock shares and warrants began trading today under the ticker symbols "OPGN" and "OPGNW." 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.

Dec
13
Sponsored by
Agilent Technologies

This webinar will discuss a genomic strategy that detects single nucleotide variants and copy number variants in a single assay.

Dec
15
Sponsored by
PierianDx

This webinar will be an interactive roundtable discussion on established and emerging regulatory, scientific, and medical topics related to next-generation sequencing in the clinical setting.